Related Experiment Video
Updated: Jun 18, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Hemostatic abnormalities in endocrine and metabolic disorders
Massimo Franchini1, Giuseppe Lippi, Franco Manzato
1Servizio di Immuno-ematologia e Medicina Trasfusionale, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria, 43100 Parma, Italy. mfranchini@ao.pr.it
Endocrine and metabolic diseases significantly impact hemostasis. While overt hypothyroidism links to bleeding, other endocrine disorders increase thrombotic risk, affecting coagulation and fibrinolysis.
Area of Science:
- Endocrinology
- Hematology
- Metabolic Diseases
Background:
- Hemostasis is a complex physiological system regulated by hormones.
- Endocrine and metabolic diseases can disrupt the hemostatic balance.
- Understanding these disruptions is crucial for managing patient risk.
Purpose of the Study:
- To review the effects of common endocrine and metabolic diseases on coagulation and fibrinolysis.
- To consolidate current knowledge on hormone-related hemostatic dysregulation.
Main Methods:
- Systematic review of existing literature.
- Analysis of studies investigating endocrine disorders and their impact on hemostasis.
- Focus on diseases including hypothyroidism, hyperthyroidism, Cushing's syndrome, pituitary dysfunctions, PCOS, and metabolic syndrome.
Main Results:
- Overt hypothyroidism is associated with an increased tendency for bleeding.
- Other endocrine diseases reviewed are generally linked to an increased tendency for thrombosis.
- Coagulation and fibrinolysis abnormalities typically range from mild to moderate, with severe cases being rare.
Conclusions:
- Endocrine and metabolic diseases exert significant influence on hemostatic balance.
- Further high-quality research is necessary to fully elucidate these complex interactions.
- Clinical awareness of these associations can aid in risk assessment and patient management.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hyperthyroidism II: Pathophysiology
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hypothyroidism II: Pathophysiology
The Endocrine System

